G. Landis
Vermogen: 746 296 $ op 31-05-2026
Vermogen: 746 296 $ op 31-05-2026
G.
Michael Landis is Chief Financial Officer & Director at Polaryx Therapeutics, Inc. since 2025.
Former roles include Chief Accounting Officer at Lannett Co., Inc. from 2009 to 2013, Chief Financial Officer at Avisa Diagnostics, Inc. in 2021, and Chief Accounting Officer at Allied Security Holdings LLC.
Also served as Chief Financial Officer at Epygenix Therapeutics, Inc. Education includes undergraduate studies at Franklin & Marshall College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-02-2026 | 228.225 ( 0,48% ) | 746 296 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-06-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| AVISA DIAGNOSTICS INC. | Financieel Directeur/CFO | 01-12-2021 |
| LANNETT COMPANY, INC. | Comptroller/Controller/Auditor | 13-07-2020 |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Financieel Directeur/CFO | - |
Allied Security Holdings LLC
Allied Security Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides security guards and patrol services | Comptroller/Controller/Auditor | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Lannett Co., Inc.
Lannett Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products | Health Technology |
Allied Security Holdings LLC
Allied Security Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides security guards and patrol services | Commercial Services |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Avisa Diagnostics, Inc.
Avisa Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau